)
Haemonetics (HAE) investor relations material
Haemonetics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of eight director nominees to serve one-year terms expiring in 2027.
Advisory vote to approve compensation of named executive officers.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending April 3, 2027.
Approval of amendments and restatements to the 2019 Long-Term Incentive Compensation Plan and the 2007 Employee Stock Purchase Plan.
Other business may be transacted as properly brought before the meeting.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and FOR all proposals listed.
Shareholders of record as of May 22, 2026, are eligible to attend and vote at the meeting.
Executive compensation and say-on-pay
Advisory vote scheduled to approve compensation of named executive officers.
Proposed amendment and restatement of the Long-Term Incentive Compensation Plan.
- Annual meeting covers director elections, compensation, auditor, and plan amendments amid strong 2026 results.HAE
Proxy filing9 Jun 2026 - Conservative FY 2027 growth guidance set, with upside tied to innovation and market execution.HAE
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Strong growth, innovation, and margin expansion drive confidence in future performance.HAE
Bank of America Global Healthcare Conference 202612 May 2026 - Q4 revenue up 4.8% with margin gains; 2027 guidance targets 3–6% organic growth.HAE
Q4 20267 May 2026 - Gross margin, net income, and cash flow rose; guidance for EPS and cash flow increased.HAE
Q3 202613 Apr 2026 - Record plasma growth, innovation, and disciplined capital deployment drive future confidence.HAE
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Revenue up 8% with strong Hospital growth; guidance and margin targets reaffirmed.HAE
Q1 20252 Feb 2026 - Q2 revenue up 8.6% and adjusted EPS up 13%, led by strong Hospital segment growth.HAE
Q2 202516 Jan 2026 - High-margin growth and innovation across core platforms drive strong financial performance and value creation.HAE
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026
Next Haemonetics earnings date
Next Haemonetics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)